Sciatic Pain – Pipeline Review, H1 2012

http://www.aarkstore.com/reports/Sciatic-Pain-Pipeline-Review-H1-2012-208336.html

You can also request for sample page of above mention reports on sample@aarkstore.com

Summary

Global Markets Direct’s, Sciatic Pain - Pipeline Review, H1 2012, provides an overview of the Sciatic Pain therapeutic pipeline. This report provides information on the therapeutic development for Sciatic Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sciatic Pain. Sciatic Pain - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Sciatic Pain.

- A review of the Sciatic Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Table of contents:

List of Tables 3

List of Figures 3

Introduction 4

Global Markets Direct Report Coverage 4

Cardiogenic Shock Overview 5

Therapeutics Development 6

An Overview of Pipeline Products for Cardiogenic Shock 6

Cardiogenic Shock Therapeutics under Development by Companies 8

Mid Clinical Stage Products 9

Comparative Analysis 9

Early Clinical Stage Products 10

Comparative Analysis 10

Cardiogenic Shock Therapeutics – Products under Development by Companies 11

Companies Involved in Cardiogenic Shock Therapeutics Development 12

Cardiome Pharma Corp 12

Curacyte AG 13

Cardiogenic Shock – Therapeutics Assessment 14

Assessment by Monotherapy Products 14

Assessment by Route of Administration 15

Assessment by Molecule Type 17

Drug Profiles 19

List of Figures

List of Tables are also include.

For more related Reports Plz follow The link:

Pipeline Review, H1 2012

http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012&PubId=&pagenum=1

Sciatic Pain – Pipeline Review, H1 2012

Cardiogenic Shock – Pipeline Review, H1 2012

Chronic Drooling – Pipeline Review, H1 2012

Fabry Disease – Pipeline Review, H1 2012

Lyme Disease – Pipeline Review, H1 2012

Esophagitis – Pipeline Review, H1 2012

Retinitis Pigmentosa (Retinitis) – Pipeline Review, H1 2012

Cellulite – Pipeline Review, H1 2012

HIV Pain – Pipeline Review, H1 2012

Tropical Spastic Paraparesis – Pipeline Review, H1 2012

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare

http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1

For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585